Top compounds associated with response to SLX1B


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.039 0.3
mRNA PF-573228 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA nintedanib CTRPv2 pan-cancer AAC -0.042 0.3
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.039 0.3
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC -0.041 0.3
mRNA AA-COCF3 CTRPv2 pan-cancer AAC 0.039 0.3
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC -0.035 0.3
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC -0.035 0.3
mRNA BCL-LZH-4 CTRPv2 pan-cancer AAC -0.058 0.3
Download CSV